Evidence map›Paper›PMID 25744228›Full record

ArticleVaccine2015

Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts.

Dimitrios G Koutsonanos, E Stein Esser, Sean R McMaster, Priya Kalluri, Jeong-Woo Lee, Mark R Prausnitz, Ioanna Skountzou, Timothy L Denning, Jacob E Kohlmeier, Richard W Compans

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Vaccine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Microneedles: Selected Applications for Pediatrics.Children (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Roles of Lipids in the Permeability Barriers of Skin and Oral Mucosa.International journal of molecular sciences · 2021
    Review
  7. Development of vaccine formulations: past, present, and future.Drug delivery and translational research · 2021
    Review
  8. Progress in microneedle array patch (MAP) for vaccine delivery.Human vaccines & immunotherapeutics · 2021
    Article
  9. Progress in Microneedle-Mediated Protein Delivery.Journal of clinical medicine · 2020
    Review
  10. Review
  11. Extended delivery of vaccines to the skin improves immune responses.Journal of controlled release : official journal of the Controlled Release Society · 2019
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Dimitrios G KoutsonanosDepartment of Microbiology & Immunology, Emory University School of Medicine, 1518 Clifton Road, Atlanta, GA 30322, United States; Influenza Pathogenesis and Immunology Research Center (IPIRC), Emory University School of Medicine, 1462 Clifton Road, Atlanta, GA 30322, United States; Emory Vaccine Center, Emory University School of Medicine, 1510 Clifton Road, Atlanta, GA 30322, United States.
E Stein EsserDepartment of Microbiology & Immunology, Emory University School of Medicine, 1518 Clifton Road, Atlanta, GA 30322, United States; Emory Vaccine Center, Emory University School of Medicine, 1510 Clifton Road, Atlanta, GA 30322, United States.
Sean R McMasterDepartment of Microbiology & Immunology, Emory University School of Medicine, 1518 Clifton Road, Atlanta, GA 30322, United States; Influenza Pathogenesis and Immunology Research Center (IPIRC), Emory University School of Medicine, 1462 Clifton Road, Atlanta, GA 30322, United States.
Priya KalluriSchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology, 311 Fest Drive, Atlanta, GA 30332-0100, United States.
Jeong-Woo LeeSchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology, 311 Fest Drive, Atlanta, GA 30332-0100, United States.
Mark R PrausnitzSchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology, 311 Fest Drive, Atlanta, GA 30332-0100, United States.
Ioanna SkountzouDepartment of Microbiology & Immunology, Emory University School of Medicine, 1518 Clifton Road, Atlanta, GA 30322, United States; Influenza Pathogenesis and Immunology Research Center (IPIRC), Emory University School of Medicine, 1462 Clifton Road, Atlanta, GA 30322, United States; Emory Vaccine Center, Emory University School of Medicine, 1510 Clifton Road, Atlanta, GA 30322, United States.
Timothy L DenningCenter for Inflammation, Immunity, and Infection, Institute of Biomedical Sciences, Georgia State University, Atlanta, GA 30303, United States.
Jacob E KohlmeierDepartment of Microbiology & Immunology, Emory University School of Medicine, 1518 Clifton Road, Atlanta, GA 30322, United States; Influenza Pathogenesis and Immunology Research Center (IPIRC), Emory University School of Medicine, 1462 Clifton Road, Atlanta, GA 30322, United States.
Richard W CompansDepartment of Microbiology & Immunology, Emory University School of Medicine, 1518 Clifton Road, Atlanta, GA 30322, United States; Influenza Pathogenesis and Immunology Research Center (IPIRC), Emory University School of Medicine, 1462 Clifton Road, Atlanta, GA 30322, United States; Emory Vaccine Center, Emory University School of Medicine, 1510 Clifton Road, Atlanta, GA 30322, United States. Electronic address: rcompan@emory.edu.
Emory Healthcare · USGeorgia Institute of Technology · USEmory University · USGeorgia State University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008169 · NIGMS · EMORY UNIVERSITY · PI GROSS, ROBERT E · 1987 to 2021
$20.3M
Influenza vaccination using a microneedle patchU01EB012495 · NIBIB · GEORGIA INSTITUTE OF TECHNOLOGY · PI PRAUSNITZ, MARK R. · 2010 to 2015
$9.6M
Skin Vaccination Against Influenza in the Young And AgedR01AI110680 · NIAID · EMORY UNIVERSITY · PI COMPANS, RICHARD W · 2015 to 2019
$3.9M
NIAID NIH HHS AI110680NIAID NIH HHS HHSN266200700006CNIAID NIH HHS R01 AI110680NIBIB NIH HHS U01 EB012495NIBIB NIH HHS U01EB012495NIGMS NIH HHS T32 GM008169PHS HHS HHSN266200700006
6 · The paper itself

Abstract

Skin has gained substantial attention as a vaccine target organ due to its immunological properties, which include a high density of professional antigen presenting cells (APCs). Previous studies have demonstrated the effectiveness of this vaccination route not only in animal models but also in adults. Young children represent a population group that is at high risk from influenza infection. As a result, this group could benefit significantly from influenza vaccine delivery approaches through the skin and the improved immune response it can induce. In this study, we compared the immune responses in young BALB/c mice upon skin delivery of influenza vaccine with vaccination by the conventional intramuscular route. Young mice that received 5 μg of H1N1 A/Ca/07/09 influenza subunit vaccine using MN demonstrated an improved serum antibody response (IgG1 and IgG2a) when compared to the young IM group, accompanied by higher numbers of influenza-specific antibody secreting cells (ASCs) in the bone marrow. In addition, we observed increased activation of follicular helper T cells and formation of germinal centers in the regional lymph nodes in the MN immunized group, rapid clearance of the virus from their lungs as well as complete survival, compared with partial protection observed in the IM-vaccinated group. Our results support the hypothesis that influenza vaccine delivery through the skin would be beneficial for protecting the high-risk young population from influenza infection.

Indexed as

AnimalsAntibodies, ViralDrug Delivery SystemsFemaleImmunoglobulin GInfluenza A Virus, H1N1 SubtypeInfluenza VaccinesInjections, IntradermalInjections, IntramuscularLungMice, Inbred BALB CModels, AnimalOrthomyxoviridae InfectionsSurvival AnalysisT-LymphocytesTreatment OutcomeAntibodies, ViralImmunoglobulin GInfluenza VaccinesVaccines, SubunitInfluenzaSkin immunizationVaccine

Identifiers

PMID25744228
PMCPMC5757502
OpenAlexW2036695118

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.